Bumper Offer - Urjas oil Just @ Rs. 1
Lemolate is a commercial drug that is prescribed in the form of Tablet. Secondary and off-label uses of Lemolate have also been mentioned below.
The optimal dosage of Lemolate is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
Some other side effects of Lemolate have been listed ahead. Such side effects of Lemolate normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Lemolate has a Moderate effect for pregnant women and Mild effect on lactating mothers. In addition, Lemolate's effects on the liver, heart and kidney are discussed below in the Lemolate related warnings section.
Lemolate is contraindicated in people with pre-existing medical conditions like Kidney Disease, Liver Disease, Drug Allergies as it can result in adverse effects. The section on Lemolate contraindications lists all such conditions.
Drug reaction of Lemolate with other medicines has been reported. See below for a complete list.
In addition to the above precautions for Lemolate, it is important to know that it is not safe while driving, and is not habit-forming.
Lemolate is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Lemolate is used -
Severe
Moderate
Mild
Is the use of Lemolate safe for pregnant women?
Lemolate Gold can have harmful effects in pregnant women. If you experience any discomfort after using Lemolate Gold, then discontinue the use and take your doctor's advice.
Is the use of Lemolate safe during breastfeeding?
Breastfeeding women can take Lemolate Gold as it bears very minor side effects for them.
What is the effect of Lemolate on the Kidneys?
Lemolate Gold may have mild side effects on the kidneys.
What is the effect of Lemolate on the Liver?
Side effects of Lemolate Gold rarely affect the liver.
What is the effect of Lemolate on the Heart?
Side effects of Lemolate Gold rarely affect the heart.
Lemolate should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Lemolate unless your doctor advises you to do so -
Is this Lemolate habit forming or addictive?
Forming a habit of Lemolate has not been reported.
Interaction between Food and Lemolate
You can take Lemolate with food.
Interaction between Alcohol and Lemolate
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Lemolate.
This medicine data has been created by -
References
KD Tripathi. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 206-207
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Acetaminophen (acetaminophen)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ofirmev (acetaminophen)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 488
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vazculep (phenylephrine hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 135-136
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1020-1022
